Ebola Death Toll Exceeds 2,000 Amid Vaccine Race

The current Ebola outbreak caused by the Bundibugyo species has reached over 4,000 confirmed cases, making it the second-largest and fastest-growing epidemic on record, according to Democratic Republic of Congo health officials who declared the outbreak on 15 May. The World Health Organization subsequently declared the emergency a public health emergency of international concern on 17 May, as the death toll climbs close to the total fatalities recorded during the 2018 to 2020 epidemic.

Vaccine Trials and Mutation Concerns in the Democratic Republic of Congo

Alarmed by the rapid transmission rates, local health officials have raised concerns that the virus could be mutating. In response to these threats, the director of the Africa Centres for Disease Control and Prevention met with WHO Director-General Tedros Adhanom Ghebreyesus to investigate the mutating threat. Currently, there are no approved vaccines or treatments for the Bundibugyo strain. However, vaccine trials have been authorized in Canada and the UK, though results remain several months away. Professor Katrina Pollock, MRC Clinician Scientist in Vaccinology and Chief Investigator at the Oxford Vaccine Group, noted that launching the first-in-human study of a Bundibugyo ebolavirus vaccine marks an important milestone achieved through significant efforts across vaccine development, manufacturing, and clinical testing, according to coverage from healthcare-digital.com. Meanwhile, treatment trials are actively underway in the DRC’s Ituri province, which serves as the epicentre of the outbreak.

Security Challenges and Humanitarian Access in Eastern DRC

Controlling the outbreak in eastern DRC remains difficult due to ongoing violence by non-State armed groups and a lack of accessible healthcare for vulnerable populations. The UN’s senior Ebola coordinator in the DRC, Julian Harneis, stated that aid workers, organizations, governments, donors, and local communities must do more today to save lives and stop Ebola. Compounding the healthcare crisis, at least a dozen treatment facilities have been attacked, driven largely by fear, misinformation, and deep community mistrust of outside authorities. According to WHO reports, between 60 to 70 percent of Ebola deaths occur in communities because many patients cannot see a doctor until it is too late.

Regional Conflict and UN Preparedness Efforts

The humanitarian response faces additional hurdles from the ongoing conflict between the Congolese military and the Rwanda-backed M23 militia. According to the UN’s humanitarian aid office, known as OCHA, at least 13 civilians were killed, several individuals were abducted, and homes were burned in an attack on the village of Banana École in Ituri, forcing more than 28,000 people to flee. News reports indicate these attacks were likely carried out by militants affiliated with the local ISIL terrorist group. UN Deputy Spokesperson Farhan Haq stated that partners continue to support the response, but security issues hinder the work. OCHA is actively working with partners to prepare neighboring Rwanda for a potential spread. While Rwanda has confirmed no Ebola Bundibugyo cases, it remains at risk due to frequent border crossings. WHO has trained Rwandan healthcare workers on prevention and surveillance, while the UN collaborates with local authorities to improve screening, traveller monitoring, personnel deployment, protective equipment provision, and community engagement.

The Race to Develop a Bundibugyo Ebola Virus Vaccine
Photo: healthcare-digital.com

Did you know? Only the 2014 to 2016 West African outbreak, which infected over 28,600 people and claimed 11,325 lives, surpassed the current Bundibugyo epidemic in overall scale, according to healthcare-digital.com.

Frequently Asked Questions

What caused the current Ebola outbreak?

The current outbreak is caused by the Bundibugyo species of the Ebola virus and was declared by DRC health officials on 15 May.

Ebola's Death Toll: 50x Deadlier Than COVID

Are there approved vaccines for the Bundibugyo strain?

There are currently no approved vaccines or treatments for the Bundibugyo strain, though vaccine trials are underway in the UK and Canada, and treatment trials are taking place in the DRC’s Ituri province.

Why is the outbreak difficult to control?

According to UN reports, the response is hindered by ongoing violence from non-State armed groups, attacks on treatment facilities, misinformation, deep community mistrust, and a lack of accessible healthcare.

If you found this report informative, please leave a comment below, explore our other global health coverage, or subscribe to our newsletter for timely updates.

Leave a Comment